Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Deferasirox

Australian Public Assessment Report

AusPAR

AusPAR: Deferasirox [PDF, 577.79 KB]

AusPAR: Deferasirox [DOCX, 428.44 KB]

Attachment: Product Information: Deferasirox [PDF, 251.03 KB]

Attachment: Product Information: Deferasirox [DOCX, 73.8 KB]

Attachment: Extract from Clinical Evaluation Report: Deferasirox [PDF, 513.89 KB]

Attachment: Extract from Clinical Evaluation Report: Deferasirox [DOCX, 409.6 KB]

Device/Product Name

Exjade

Active ingredients

Deferasirox

AusPAR Date

6 March 2014

Published

3 April 2014

Submission Number

PM-2012-03063-1-4

Submission Type

Extension of indications

Decision

Approved

Product types

Prescription medicines